CD4 and neoplasm: In the primary tumor site, CD4+ T cell-depleted animals showed almost completely suppressed residual tumor growth, whereas nondepleted PDT + FlaB-Vax-treated animals manifested tumor regrowth from day 7 (Figure 4A).